AG2R La Mondiale Gestion d'Actifs’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.88M Buy
67,511
+6,486
+11% +$352K 0.1% 182
2026
Q1
$3.83M Buy
61,025
+1,481
+2% +$118K 0.17% 113
2025
Q4
$5.68M Buy
59,544
+3,812
+7% +$374K 0.25% 78
2025
Q3
$5.99M Hold
55,732
0.31% 61
2025
Q2
$5.99M Buy
55,732
+888
+2% +$89.8K 0.31% 61
2025
Q1
$5.77M Buy
+54,844
New +$5.52M 0.31% 60

Other funds holding BSX

AG2R La Mondiale Gestion d'Actifs's BSX Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its Boston Scientific (BSX) stake by 11% in Q2 2026, buying an estimated $352K and bringing the position to 67,511 shares worth $2.88M. The position accounts for 0.1% of the portfolio, ranked #182.

AG2R La Mondiale Gestion d'Actifs first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.99M in Q3 2025. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • AG2R La Mondiale Gestion d'Actifs held 67,511 shares of Boston Scientific worth $2.88M as of Q2 2026.
  • AG2R La Mondiale Gestion d'Actifs bought 6,486 Boston Scientific shares in Q2 2026, an estimated $352K.
  • Boston Scientific made up 0.1% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #182 holding.
  • AG2R La Mondiale Gestion d'Actifs first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • AG2R La Mondiale Gestion d'Actifs's Boston Scientific position peaked at $5.99M in Q3 2025.
  • 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.